Jannis Kitsakis representing AP4
As the conveyer of the Nomination Committee,
The function of the Nomination Committee is to prepare and submit proposals for the AGM regarding the number of board members to be elected by the general meeting, election of chairman and other board members, board fees and any remuneration for committee work, election of the chairman of the AGM, election of auditors (if applicable) and fee for the auditors, and proposals for rules for appointing the Nomination Committee.
The proposals of the Nomination Committee will be presented in the notice of the Annual General Meeting 2023 and will be published on
Shareholders wishing to submit comments or proposals to the Nomination Committee may do so via e-mail to ir@hansabiopharma.com or by letter to
This disclosure contains information that
Contact:
Head of Investor Relations
Mobile: +46 (0) 709-298 269
E-mail: klaus.sindahl@hansabiopharma.com
(C) 2022 Electronic News Publishing, source